Ticagrelor versus Adjusted‐Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention

Dual antiplatelet therapy (DAPT) with ticagrelor or adjusted‐dose prasugrel has been used for acute coronary syndrome (ACS). However, few studies have directly compared these two drugs. In this study, we compared the real‐world applications and outcomes of these two drugs in patients with ACS who ha...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical pharmacology and therapeutics Vol. 116; no. 3; pp. 747 - 756
Main Authors:	Tsai, Ming‐Lung, Lin, Yuan, Chen, Dong‐Yi, Lin, Ming‐Shyan, Wang, Chao‐Yung, Hsieh, I‐Chang, Yang, Ning‐I, Hung, Ming‐Jui, Chen, Tien‐Hsing
Format:	Journal Article
Language:	English
Published:	United States 01.09.2024
Subjects:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - therapy Aged Female Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Male Middle Aged Percutaneous Coronary Intervention - adverse effects Platelet Aggregation Inhibitors - administration & dosage Platelet Aggregation Inhibitors - adverse effects Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride - administration & dosage Prasugrel Hydrochloride - adverse effects Prasugrel Hydrochloride - therapeutic use Retrospective Studies Ticagrelor - administration & dosage Ticagrelor - adverse effects Ticagrelor - therapeutic use Treatment Outcome
ISSN:	0009-9236, 1532-6535, 1532-6535
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!